Heartware International (Heartware International) Other Net Income (Loss) : $0.0 Mil (TTM As of Jun. 2016)

View and export this data going back to 2008. Start your Free Trial

What is Heartware International Other Net Income (Loss)?

Heartware International's Other Net Income (Loss) for the three months ended in Jun. 2016 was $0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2016 was $0.0 Mil.

Heartware International's quarterly Other Net Income (Loss) increased from Dec. 2015 ($-0.0 Mil) to Mar. 2016 ($0.0 Mil) and increased from Mar. 2016 ($0.0 Mil) to Jun. 2016 ($0.0 Mil).

Heartware International Other Net Income (Loss) Historical Data

The historical data trend for Heartware International's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International Other Net Income (Loss) Chart

Heartware International Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Other Net Income (Loss)

Get a 7-Day Free Trial

Heartware International Quarterly Data
	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Heartware International Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Heartware International Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Heartware International's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Heartware International (Heartware International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International Inc (NAS:HTWR) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.heartware.com

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Executives

Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Stephen N. Oesterle	director	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Seth Loring Harrison	director	230 PARK AVENUE, SUITE 2800, NEW YORK NY 10169
Timothy J Barberich	director	40 ELM ST, CONCORD MA 01752
Douglas Evan Godshall	director, officer: President & Chief Exec Officer	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Robert Bain Thomas	director	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Denis Newell Wade	director	SUITE 4 LEVEL 46, 2 PARK STREET, SIDNEY C3 2000
Adage Capital Partners Gp, L.l.c.	10 percent owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Adage Capital Partners, L.p.	10 percent owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Adage Capital Advisors, L.l.c.	10 percent owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Robert Atchinson	10 percent owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Phillip Gross	10 percent owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
David Mcintyre	officer: CFO & COO	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Muneer A Satter	10 percent owner	C/O SATTER INVESTMENT MANAGEMENT, LLC, 676 NORTH MICHIGAN AVENUE, SUITE 4000, CHICAGO IL 60611